Bonus BioGroup Ltd.

Equities

BONS

IL0004850116

Biotechnology & Medical Research

Market Closed - TEL AVIV STOCK EXCHANGE Other stock markets 07:24:08 2024-04-25 am EDT			5-day change	1st Jan Change
16.8 ^ILa	-0.59%		+3.07%	+0.60%

Mar. 29	Bonus BioGroup Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Bonus BioGroup Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Bonus BioGroup Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023

May 29, 2023 at 10:51 am EDT

Bonus BioGroup Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was ILS 7.62 million compared to ILS 7.3 million a year ago.

Latest news about Bonus BioGroup Ltd.

Bonus BioGroup Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 29	CI
Bonus BioGroup Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 30	CI
Bonus BioGroup Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-31	CI
Bonus BioGroup Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-29	CI
Bonus BioGroup Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-30	CI
Bonus Biogroup Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-31	CI
Bonus BioGroup Ltd. announced that it expects to receive ILS 9 million in funding	17-04-10	CI
Bonus BioGroup Ltd. Auditor Raises 'Going Concern' Doubt	17-03-30	CI
Bonus BioGroup Ltd. announced that it has received ILS 8 million in funding	16-11-27	CI
Bonus BioGroup Ltd. announced that it expects to receive $1.46 million in funding	16-11-24	CI
Bonus BioGroup Ltd. announced that it expects to receive ILS 8 million in funding	16-10-04	CI
Bonus BioGroup Ltd. announced that it expects to receive ILS 4 million in funding	16-07-09	CI

Chart Bonus BioGroup Ltd.

Duration

Period

More charts

Company Profile

Bonus Biogroup Ltd, formerly Oceana Advanced Industries Ltd, is an Israel-based product-focused biotechnology company applying technology for supplying bone regeneration tissues. The Company is developing cell therapy products based on autologous and allogeneic bone implants that will enable efficient bone transplant and provide cellular-based bone replacement prosthetics for repairing bone lesions. It is targeting a worldwide market for the treatment of major disorders such as bone and cartilage related arthritis, osteoporosis, and various types of bones and joint trauma such as hip fractures and knee injuries, among others. On April 29, 2012, Bonus Bio Group Ltd fully acquired Bonus Therapeutic Ltd.

Sector

Biotechnology & Medical Research

More about the company

Income Statement Evolution

More financial data

Sector Bio Medical Devices

	1st Jan change	Capi.
BONUS BIOGROUP LTD.	+0.60%	51.45M
MIMEDX GROUP, INC.	-28.51%	925M
NIBEC CO., LTD.	-20.60%	128M
COLLPLANT BIOTECHNOLOGIES LTD.	-7.82%	67.46M
KIM FOREST ENTERPRISE CO., LTD.	+6.64%	60.58M
NOVACYT	+14.87%	61.68M

Bio Medical Devices